Profile

MD, Case Western Reserve University






Distress Tolerance and Benzodiazepine Discontinuation in Opioid Agonist Therapy
08/15/2017 - 07/31/2022 (PI)
NIH-NIDA
5K23DA044321-03

(SAMHSA) Addiction and Behavioral Health Outpatient Recovery (A.B.O.V.E)
09/30/2018 - 09/29/2021 (PI)
SAMHSA


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Park TW, Sikov J, dellaBitta V, Saitz R, Walley AY, Drainoni ML. "It could potentially be dangerous... but nothing else has seemed to help me.": Patient and clinician perspectives on benzodiazepine use in opioid agonist treatment. J Subst Abuse Treat. 2021 Apr 30; 131:108455.View Related Profiles. PMID: 34098286
     
  2. Park TW, Larochelle MR, Saitz R, Wang N, Bernson D, Walley AY. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine. Addiction. 2020 05; 115(5):924-932.View Related Profiles. PMID: 31916306; PMCID: PMC7156323; DOI: 10.1111/add.14886;
     
  3. Hadland SE, Park TW, Bagley SM. Stigma associated with medication treatment for young adults with opioid use disorder: a case series. Addict Sci Clin Pract. 2018 05 07; 13(1):15.View Related Profiles. PMID: 29730987; PMCID: PMC5937046; DOI: 10.1186/s13722-018-0116-2;
     
  4. Park TW. Debate: Are Benzodiazepines Appropriate Treatments for Patients with Substance Use Disorders? Yes. J Addict Med. 2017 Mar/Apr; 11(2):87-89. PMID: 28301370; DOI: 10.1097/ADM.0000000000000292;
     
  5. Lin LA, Hosanagar A, Park TW, Bohnert AS. Opioid Overdose: Risk Assessment and Mitigation in Outpatient Treatment. J Addict Med. 2016 Nov/Dec; 10(6):382-386. PMID: 27525469; PMCID: PMC5083151; DOI: 10.1097/ADM.0000000000000241;
     
  6. Park TW, Lin LA, Hosanagar A, Kogowski A, Paige K, Bohnert AS. Understanding Risk Factors for Opioid Overdose in Clinical Populations to Inform Treatment and Policy. J Addict Med. 2016 Nov/Dec; 10(6):369-381. PMID: 27525471
     
  7. Ramsey SE, Rounsaville D, Hoskinson R, Park TW, Ames EG, Neirinckx VD, Friedmann P. The Need for Psychosocial Interventions to Facilitate the Transition to Extended-Release Naltrexone (XR-NTX) Treatment for Opioid Dependence: A Concise Review of the Literature. Subst Abuse. 2016; 10:65-8. PMID: 27512336; PMCID: PMC4975246; DOI: 10.4137/SART.S39067;
     
  8. Park TW, Saitz R, Nelson KP, Xuan Z, Liebschutz JM, Lasser KE. The association between benzodiazepine prescription and aberrant drug-related behaviors in primary care patients receiving opioids for chronic pain. Subst Abus. 2016 Oct-Dec; 37(4):516-520.View Related Profiles. PMID: 27092738; PMCID: PMC5708125; DOI: 10.1080/08897077.2016.1179242;
     
  9. Park TW, Cheng DM, Lloyd-Travaglini CA, Bernstein J, Palfai TP, Saitz R. Changes in health outcomes as a function of abstinence and reduction in illicit psychoactive drug use: a prospective study in primary care. Addiction. 2015 Sep; 110(9):1476-83.View Related Profiles. PMID: 26075702; PMCID: PMC4521992; DOI: 10.1111/add.13020;
     
  10. Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ. 2015; 350:h2698.View Related Profiles. PMID: 26063215; PMCID: PMC4462713; DOI: 10.1136/bmj.h2698;
     
Showing 10 of 18 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 1 publications over 1 distinct years, with a maximum of 1 publications in 2007

YearPublications
20071
Contact for Mentoring:

Media Mentions
_